What a test can show
Comprehensive clinical PALB2 analysis for SNVs/indels and deletions/duplications; a tumour finding may require germline confirmation in blood or saliva.
Monogenic conditions
PALB2Hereditary cancer predisposition
Pathogenic germline variants raise breast-cancer risk and can matter in other cancers, including pancreatic cancer.
RELATIONSHIP VALIDITYHigh: established gene–disease relationship
ACTIONABILITYHigh after clinical confirmation
SOURCE CHECKLinks and claim boundaries are editorially checked; external expert review is stated only with named disclosure
Practical meaning
A result may change surveillance and family testing; treatment relevance depends on tumour type and the current label.
Where knowledge ends
A tumour variant does not prove germline origin, and a VUS is not a basis for preventive surgery or targeted treatment.
SOURCES AND VERSION
Verifiable, not ‘trust us’.
Updated: 14 August 2026. Any clinical interpretation requires the exact variant, testing method, family information and medical context.